• Home
  • Media
  • Sitemap
  • About Us
    • The company
      • Brief Profile
      • Vision
      • Mission 2013
      • Key Milestones
      • Board of Directors
      • Key Management Team
    • Parabolic Drugs in News
    • Media Gallery
  •  Our Business
    • CRAMS
      • Infrastructure
      • Capabilities
      • Our Business Model
      • Why PDL?
      • Contact CRAMS Division
    • APIs
      • Segments
      • Manufacturing Facilities
      • Our Products
      • Accreditations
      • Contact us for APIs
    • R & D
      • R&D Centre, Barwala
      • R&D Lab, Derabassi
      • IPR,QA & QC
  •  Global Presence
    • Market Presence
    • Regulatory Affairs
    • Business Opportunities
      • Contract Research
      • Contract manufacturing
      • Strategic tieups for Global Marketing
  • Human Resources
    • HR at PDL
      • HR Vision
      • HR Goals
    • Work with us
      • Current Openings
      • Upload your CV
  • CSR
    • CSR Initiatives
    • Environmental Concern
    • Health and Safety
  • Investor Relations
    • MD's Address
    • Corporate Governance
    • Latest Financial Results
    • Key Financial Indicators
    • Shareholding Pattern
    • Annual Reports
    • Track PDL's Share
    • Contact IR
  • Contact us

Latest Financial Results

 

FY 2012

Financial Results for the Quarter ended on 31st March,2011(Unaudited)

Financial Results for the Quarter ended on 30th September,2011(Unaudited)

Financial Results for the Quarter ended on 30th June,2011(Unaudited)

FY 2011

Financial Results for the Year ended 31st March,2011(Audited)

Financial Results for the Quarter ended on 31st March,2011(Unaudited)

Financial Results for the Quarter ended on 31st December,2010(Unaudited)

Financial Results for the Quarter ended on 30th September,2010(Unaudited)

Financial Results for the Quarter ended on 30th June,2010(Unaudited)

FY 2010

Financial Results for the Quarter ended on 31st March,2010

 

Go Back | Home